Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation
Sponsor: Urmia University of Medical Sciences
This PHASE3 trial investigates Paroxysmal Atrial Fibrillation and Sick Sinus Syndrome and is currently completed. Urmia University of Medical Sciences leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Urmia University of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .